Company Quick10K Filing
Progress Software
10-Q 2021-02-28 Filed 2021-04-05
10-K 2020-11-30 Filed 2021-01-27
10-Q 2020-08-31 Filed 2020-10-08
10-Q 2020-05-31 Filed 2020-07-08
10-Q 2020-02-29 Filed 2020-04-07
10-K 2019-11-30 Filed 2020-01-27
10-Q 2019-08-31 Filed 2019-10-07
10-Q 2019-05-31 Filed 2019-07-09
10-Q 2019-02-28 Filed 2019-04-05
10-K 2018-11-30 Filed 2019-01-28
10-Q 2018-08-31 Filed 2018-10-05
10-Q 2018-05-31 Filed 2018-07-06
10-Q 2018-02-28 Filed 2018-04-06
10-K 2017-11-30 Filed 2018-01-26
10-Q 2017-08-31 Filed 2017-10-10
10-Q 2017-05-31 Filed 2017-07-07
10-Q 2017-02-28 Filed 2017-04-07
10-K 2016-11-30 Filed 2017-01-30
10-Q 2016-08-31 Filed 2016-10-07
10-Q 2016-05-31 Filed 2016-07-08
10-Q 2016-02-29 Filed 2016-04-08
10-K 2015-11-30 Filed 2016-01-29
10-Q 2015-08-31 Filed 2015-10-07
10-Q 2015-05-31 Filed 2015-07-08
10-Q 2015-02-28 Filed 2015-04-07
10-K 2014-11-30 Filed 2015-01-29
10-Q 2014-08-31 Filed 2014-10-09
10-Q 2014-05-31 Filed 2014-07-08
10-Q 2014-02-28 Filed 2014-04-09
10-K 2013-11-30 Filed 2014-01-29
10-Q 2013-08-31 Filed 2013-10-09
10-Q 2013-02-28 Filed 2013-04-09
10-K 2012-11-30 Filed 2013-01-29
10-Q 2012-08-31 Filed 2012-10-10
10-Q 2012-05-31 Filed 2012-07-10
10-Q 2012-02-29 Filed 2012-04-09
10-K 2011-11-30 Filed 2012-01-30
10-Q 2011-08-31 Filed 2011-10-11
10-Q 2011-05-31 Filed 2011-07-08
10-Q 2011-02-28 Filed 2011-04-11
10-K 2010-11-30 Filed 2011-01-31
10-Q 2010-08-31 Filed 2010-10-12
10-Q 2010-05-31 Filed 2010-07-09
10-Q 2010-02-28 Filed 2010-04-09
10-K 2009-11-30 Filed 2010-01-29
8-K 2020-10-05
8-K 2020-09-29
8-K 2020-09-08
8-K 2020-09-04
8-K 2020-06-25
8-K 2020-05-14
8-K 2020-03-26
8-K 2020-01-16
8-K 2020-01-16
8-K 2019-10-24
8-K 2019-10-04
8-K 2019-09-26
8-K 2019-06-27
8-K 2019-06-21
8-K 2019-05-09
8-K 2019-04-30
8-K 2019-03-28
8-K 2019-03-28
8-K 2019-03-19
8-K 2019-01-17
8-K 2018-09-27
8-K 2018-06-27
8-K 2018-05-17
8-K 2018-04-13
8-K 2018-03-28
8-K 2018-03-06
8-K 2018-02-20
8-K 2018-01-10

Progress Software Financials

PRGS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-08-312010-11-302011-02-282011-05-312011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash269322371389347261315328352355321256242231248227261283211199218241251229233250264245191184167144138140133129
Accounts Receivable8511910492841111038676716451546759585868605660665948566649445261544346585552
Inventory
PP&E5858606366129686664127625957105616059115625857110535251111484543111424243882933
Assets860937966960911865909899906885780711687682690673677703890877887877877834833755741737726719683637625641616830
Accounts Payable613786769510976108971210109111210101399799108111010
Long-Term Debt11100148146144144141139137135131128124124122121119118116301
Liabilities227248251243240243255240227247185169167169166155152160352354357355354343338348355344334343335328320331309515
Stockholders' Equity633688715717671622653660679638596542519514525519524543538523530522523491495407386393392376348309305310307315
Income Statement ($MM)2010-08-312010-11-302011-02-282011-05-312011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue129145134140128136124115107918982789175817998818995113899610211891939711694969611190100
Cost of Revenue252524262726252620-23118988789181615151616171716171818171717171618
Gross Profit1041201101151021109989878078736983677371876473809774808510175767998777979957482
R&D
SG&A5160576366686360471446403841363635434546444742414143363334393334343537
Tax610812488561476143376122-101228645100881635444
Net Income92121299127-2636314251511131114-16-4-9378-74-11011161315171898
Cash Flow ($MM)2010-08-312010-11-302011-02-282011-05-312011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating26503929839152228-2514-218251726393721192723272034372213333242232441
Cash Investing-24-26-20-17-3917-4265583-648-60-1030-15-249-122-1-20-33-15-39-47-7-2157-218
Cash Financing27-3-23-66-561454-78-80-65-48-32-6-26-143142-2620-9-51-13-9-23-18-27-35-51-53-25-32177